Approval · Notice of Compliance 22885 · 2019
ACARBOSE TABLETS: Notice of Compliance 22885
Issued November 8, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22885
- Date
- November 8, 2019
- Company
- Strides Pharma Canada IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- GLUCOBAY (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACARBOSE TABLETS | 02493780 | Dormant |
| ACARBOSE TABLETS | 02493799 | Dormant |